A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - ONCOLOGYNEWS.COM.AU - A La Une - 12/Dec 03:23
Oncologists hesitant to intensify treatment for advanced prostate cancer
A recent study has revealed a significant gap between guidelines and clinical practice in the treatment of metastatic prostate cancer. A survey of US-based physicians, published in JAMA Network Open, highlighted a concerning trend: many doctors are not prescribing optimal treatment intensification (TI) for patients with metastatic castration-sensitive prostate cancer (mCSPC). This is despite strong [...]
Articles similaires
Cannabidiol Safe, May Lower Anxiety in Advanced Breast Cancer
drugs.com - 20/Dec 17:12
FRIDAY, Dec. 20, 2024 -- For patients with advanced breast cancer and baseline clinical anxiety, cannabidiol (CBD) is safe and may reduce anxiety...
Cannabidiol Safe, May Lower Anxiety in Advanced Breast Cancer
drugs.com - 20/Dec 17:12
FRIDAY, Dec. 20, 2024 -- For patients with advanced breast cancer and baseline clinical anxiety, cannabidiol (CBD) is safe and may reduce anxiety...
Datopotamab Deruxtecan Granted Breakthrough Therapy Designation in US for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
drugs.com - 09/Dec 00:12
9 December 2024 -- Datopotamab deruxtecan (Dato-DXd) has been granted Breakthrough Therapy Designation (BTD) in the US for the treatment of adult...
FDA Approves Ensacove (ensartinib) for ALK-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
drugs.com - 18/Dec 00:12
On December 18, 2024, the Food and Drug Administration approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for adult patients with anaplastic...
FDA Approves Ensacove (ensartinib) for ALK-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
drugs.com - 18/Dec 00:12
On December 18, 2024, the Food and Drug Administration approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for adult patients with anaplastic...
ESC 2025: Preventing Heart Disease in Cancer Patients
medindia.net - 14/Dec 12:49
Surge in cancer patients with cardiovascular side effects due to cancer treatment. Doctors and experts urge to include heart and cardiovascular...
A low omega-6, omega-3 rich diet and fish oil may slow prostate cancer growth
oncologynews.com.au - 16/Dec 13:18
A new study led by UCLA Health Jonsson Comprehensive Cancer Center (USA) investigators offers new evidence that dietary changes may help reduce...
Survival Up With Nivolumab + Ipilimumab Versus Chemo for Metastatic CRC
drugs.com - 09/Dec 16:12
MONDAY, Dec. 9, 2024 -- For patients with microsatellite-instability-high (MSI-H) or mismatch-repair-deficient (dMMR) metastatic colorectal cancer who...
Second Opinions for Cancer in Germany: Accessing Top Oncologists
thecanary.co - 20/Dec 10:10
Cancer is one of the most complex and challenging diseases, and having the right diagnosis and treatment is essential for survival and recovery. Many...
Les derniers communiqués
-
Aucun élément